-+ 0.00%
-+ 0.00%
-+ 0.00%

Atossa Therapeutics FY2025; R&D expense climbs to $21.2 million; clinical and non-clinical trial expense rises 60% to $16.2 million

Reuters·03/25/2026 21:20:58

Please log in to view news